{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "01",
                "@year": "2021",
                "@timestamp": "2021-10-01T12:11:45.000045-04:00",
                "@month": "10"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "12"
            }
        },
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "120195070",
                            "@country": "tha",
                            "city": "Nonthaburi",
                            "organization": [
                                {"$": "The College of Pharmacotherapy of Thailand"},
                                {"$": "The Pharmacy Council"}
                            ],
                            "affiliation-id": {
                                "@afid": "120195070",
                                "@dptid": "120195917"
                            },
                            "@affiliation-instance-id": "2005618806-b9d7c95b368abf3f0cd3daffe5551a73",
                            "ce:source-text": "The College of Pharmacotherapy of Thailand, The Pharmacy Council, Nonthaburi, Thailand",
                            "@dptid": "120195917"
                        },
                        "author": [{
                            "ce:given-name": "Benjabhorn",
                            "preferred-name": {
                                "ce:given-name": "Benjabhorn",
                                "ce:initials": "B.",
                                "ce:surname": "Weeraphon",
                                "ce:indexed-name": "Weeraphon B."
                            },
                            "@seq": "1",
                            "@author-instance-id": "2005618806-56662721f25d07974001251e8fcc2a82",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PharmD",
                            "ce:surname": "Weeraphon",
                            "@auid": "57218165524",
                            "@orcid": "0000-0003-1921-8459",
                            "ce:indexed-name": "Weeraphon B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60009116",
                            "@country": "tha",
                            "city": "Chon Buri",
                            "organization": [
                                {"$": "Department of Pharmacy Practice and Pharmaceutical Care"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Burapha University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009116",
                                "@dptid": "122950643"
                            },
                            "@affiliation-instance-id": "2005618806-c1ad889e6a2e700ca4ee8e0b4467d2b0",
                            "ce:source-text": "Department of Pharmacy Practice and Pharmaceutical Care, Faculty of Pharmaceutical Sciences, Burapha University, Chon Buri, Thailand",
                            "@dptid": "122950643"
                        },
                        "author": [{
                            "ce:given-name": "Benjabhorn",
                            "preferred-name": {
                                "ce:given-name": "Benjabhorn",
                                "ce:initials": "B.",
                                "ce:surname": "Weeraphon",
                                "ce:indexed-name": "Weeraphon B."
                            },
                            "@seq": "1",
                            "@author-instance-id": "2005618806-56662721f25d07974001251e8fcc2a82",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PharmD",
                            "ce:surname": "Weeraphon",
                            "@auid": "57218165524",
                            "ce:indexed-name": "Weeraphon B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Infectious Diseases"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "2005618806-151123ca9a9f9df10a85bd66f73b7acc",
                            "ce:source-text": "Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Jakapat",
                            "preferred-name": {
                                "ce:given-name": "Jakapat",
                                "ce:initials": "J.",
                                "ce:surname": "Vanichanan",
                                "ce:indexed-name": "Vanichanan J."
                            },
                            "@seq": "2",
                            "@author-instance-id": "2005618806-aebe31becf04febc5b184dc807faef82",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Vanichanan",
                            "@auid": "55272444700",
                            "ce:indexed-name": "Vanichanan J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pharmacy Practice"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113044315"
                            },
                            "@affiliation-instance-id": "2005618806-91c1356465c062e46ff1abeacc9c6978",
                            "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113044315"
                        },
                        "author": [{
                            "ce:given-name": "Sang",
                            "preferred-name": {
                                "ce:given-name": "Sang",
                                "ce:initials": "S.",
                                "ce:surname": "Usayaporn",
                                "ce:indexed-name": "Usayaporn S."
                            },
                            "@seq": "3",
                            "@author-instance-id": "2005618806-a3dd94c72ddbf2e246885741f845b171",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "BSc(Pharm), BCIDP",
                            "ce:surname": "Usayaporn",
                            "@auid": "57218170494",
                            "ce:indexed-name": "Usayaporn S."
                        }]
                    }
                ],
                "citation-title": "Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report",
                "abstracts": "© 2020 John Wiley & Sons LtdWhat is known and objective: Triazole antifungal-associated skin rash is rare. Data on cross-reaction triazole antifungals remain inconclusive and poorly defined. We report successful voriconazole challenge in a patient allergic to posaconazole. Case summary: A 38-year-old female diagnosed with acute myeloid leukaemia and receiving chemotherapy treatment in our institution developed a maculopapular rash after receiving oral posaconazole for invasive fungal infection prophylaxis. Other potential causes that may have attributed to this response, such as other drugs that the patient was taking and infections, were excluded. Voriconazole, another triazole antifungal, was successfully substituted for posaconazole. What is new and conclusion: This is the first case report of a patient, with a history of posaconazole allergy, successfully challenged with voriconazole.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Pharmacy Practice"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Sang",
                        "ce:initials": "S.",
                        "ce:degrees": "BSc(Pharm), BCIDP",
                        "ce:surname": "Usayaporn",
                        "ce:indexed-name": "Usayaporn S."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "antifungals",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "cross-reactivity",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "hypersensitivity",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "maculopapular rash",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "posaconazole",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "triazole",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "voriconazole",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2710",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Clinical Pharmacy and Therapeutics",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "45",
                            "@issue": "6"
                        },
                        "pagerange": {
                            "@first": "1486",
                            "@last": "1488"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Clinical Pharmacy and Therapeutics",
                    "publicationdate": {
                        "month": "12",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 December 2020"
                        },
                        "day": "01"
                    },
                    "codencode": "JCPTE",
                    "sourcetitle-abbrev": "J. Clin. Pharm. Ther.",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "13652710",
                            "@type": "electronic"
                        },
                        {
                            "$": "02694727",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Blackwell Publishing Ltd"},
                    "@srcid": "23007"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3004"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "PHAR"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "132-22-9",
                                    "chemical-name": "chlorpheniramine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "147-94-4"},
                                        {"$": "69-74-9"}
                                    ],
                                    "chemical-name": "cytarabine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "57852-57-0"},
                                        {"$": "58957-92-9"}
                                    ],
                                    "chemical-name": "idarubicin"
                                },
                                {
                                    "cas-registry-number": "208538-73-2",
                                    "chemical-name": "micafungin"
                                },
                                {
                                    "cas-registry-number": "171228-49-2",
                                    "chemical-name": "posaconazole"
                                },
                                {
                                    "cas-registry-number": "137234-62-9",
                                    "chemical-name": "voriconazole"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antifungal Agents"},
                                {"chemical-name": "posaconazole"},
                                {"chemical-name": "Triazoles"},
                                {"chemical-name": "Voriconazole"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Process",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@year": "2021",
                    "@timestamp": "BST 06:44:41",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005618806",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "926947369",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200598625",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32686229",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2020275132",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20201541626",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20202641487",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20200011071446",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85088146256",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85088146256",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "632400056",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76707499",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1111/jcpt.13221"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "14",
                "reference": [
                    {
                        "ref-fulltext": "Product Information. Noxafil(R) oral delayed-release tablets, oral suspension, posaconazole oral delayed-release tablets, oral suspension. Merck Sharp & Dohme Corp. (per FDA), Whitehouse Station, NJ, 2013.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088138274",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Merck Sharp & Dohme Corp. (per FDA), Whitehouse Station, NJ",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Product Information",
                                "ce:indexed-name": "Product Information"
                            }},
                            "ref-sourcetitle": "Noxafil(R) oral delayed-release tablets, oral suspension, posaconazole oral delayed-release tablets, oral suspension"
                        },
                        "ce:source-text": "Product Information. Noxafil(R) oral delayed-release tablets, oral suspension, posaconazole oral delayed-release tablets, oral suspension. Merck Sharp & Dohme Corp. (per FDA), Whitehouse Station, NJ, 2013."
                    },
                    {
                        "ref-fulltext": "Ullmann AJ, Cornely OA, Burchardt A, et al. Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother. 2006;50(2):658-666.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "31944443967",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "50",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "658",
                                    "@last": "666"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ullmann",
                                        "ce:indexed-name": "Ullmann A.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cornely",
                                        "ce:indexed-name": "Cornely O.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Burchardt",
                                        "ce:indexed-name": "Burchardt A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Ullmann AJ, Cornely OA, Burchardt A, et al. Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother. 2006;50(2):658-666."
                    },
                    {
                        "ref-fulltext": "Cornely OA, Helfgott D, Langston A, et al. Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection. Antimicrob Agents Chemother. 2012;56(5):2652-2658.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84860117262",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "2652",
                                    "@last": "2658"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cornely",
                                        "ce:indexed-name": "Cornely O.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Helfgott",
                                        "ce:indexed-name": "Helfgott D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Langston",
                                        "ce:indexed-name": "Langston A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Cornely OA, Helfgott D, Langston A, et al. Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection. Antimicrob Agents Chemother. 2012;56(5):2652-2658."
                    },
                    {
                        "ref-fulltext": "Maertens JA, Girmenia C, Brüggemann RJ, et al. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother. 2018;73(12):3221-3230.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055174815",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "3221",
                                    "@last": "3230"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Maertens",
                                        "ce:indexed-name": "Maertens J.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Girmenia",
                                        "ce:indexed-name": "Girmenia C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Brüggemann",
                                        "ce:indexed-name": "Bruggemann R.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Maertens JA, Girmenia C, Brüggemann RJ, et al. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother. 2018;73(12):3221-3230."
                    },
                    {
                        "ref-fulltext": "NCCN Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections.Version 1. 2020. December 17, 2019.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85064680251",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "December 17",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "NCCN Clinical Practice Guidelines in Oncology",
                                "ce:indexed-name": "NCCN Clinical Practice Guidelines in Oncology"
                            }},
                            "ref-sourcetitle": "Prevention and treatment of cancer-related infections.Version 1. 2020"
                        },
                        "ce:source-text": "NCCN Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections.Version 1. 2020. December 17, 2019."
                    },
                    {
                        "ref-fulltext": "Tacke D, Buchheidt D, Karthaus M, et al. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Ann Hematol. 2014;93(9):1449-1456.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84905580152",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "93",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1449",
                                    "@last": "1456"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Tacke",
                                        "ce:indexed-name": "Tacke D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Buchheidt",
                                        "ce:indexed-name": "Buchheidt D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Karthaus",
                                        "ce:indexed-name": "Karthaus M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Hematol"
                        },
                        "ce:source-text": "Tacke D, Buchheidt D, Karthaus M, et al. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Ann Hematol. 2014;93(9):1449-1456."
                    },
                    {
                        "ref-fulltext": "Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America. Clin Infect Dis. 2011;52(4):e56-e93.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79951816939",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "52",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "e56",
                                    "@last": "e93"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Freifeld",
                                        "ce:indexed-name": "Freifeld A.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bow",
                                        "ce:indexed-name": "Bow E.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sepkowitz",
                                        "ce:indexed-name": "Sepkowitz K.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America. Clin Infect Dis. 2011;52(4):e56-e93."
                    },
                    {
                        "ref-fulltext": "Leung S, Poulakos MN, Machin J. Posaconazole: an update of its clinical use. Pharmacy (Basel). 2015;3(4):210-268.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Posaconazole: an update of its clinical use"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049790320",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "210",
                                    "@last": "268"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Leung",
                                    "ce:indexed-name": "Leung S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Poulakos",
                                    "ce:indexed-name": "Poulakos M.N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Machin",
                                    "ce:indexed-name": "Machin J."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacy (Basel)"
                        },
                        "ce:source-text": "Leung S, Poulakos MN, Machin J. Posaconazole: an update of its clinical use. Pharmacy (Basel). 2015;3(4):210-268."
                    },
                    {
                        "ref-fulltext": "Cornely OA, Duarte RF, Haider S, et al. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. J Antimicrob Chemother. 2016;71(3):718-726.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84960836988",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "718",
                                    "@last": "726"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cornely",
                                        "ce:indexed-name": "Cornely O.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Duarte",
                                        "ce:indexed-name": "Duarte R.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Haider",
                                        "ce:indexed-name": "Haider S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Cornely OA, Duarte RF, Haider S, et al. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. J Antimicrob Chemother. 2016;71(3):718-726."
                    },
                    {
                        "ref-fulltext": "Calogiuri G, Garvey LH, Nettis E, et al. Skin allergy to Azole antifungal agents for systemic use: a review of the literature. Recent Pat Inflamm Allergy Drug Discov. 2019;13(2):144-157.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Skin allergy to Azole antifungal agents for systemic use: a review of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076326668",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "144",
                                    "@last": "157"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Calogiuri",
                                        "ce:indexed-name": "Calogiuri G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Garvey",
                                        "ce:indexed-name": "Garvey L.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Nettis",
                                        "ce:indexed-name": "Nettis E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Recent Pat Inflamm Allergy Drug Discov"
                        },
                        "ce:source-text": "Calogiuri G, Garvey LH, Nettis E, et al. Skin allergy to Azole antifungal agents for systemic use: a review of the literature. Recent Pat Inflamm Allergy Drug Discov. 2019;13(2):144-157."
                    },
                    {
                        "ref-fulltext": "Benjamin Lash D, Jolliff J, Munoz A, Heidari A. Cross-reactivity between voriconazole, fluconazole and itraconazole. J Clin Pharm Ther. 2016;41(5):566-567.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Cross-reactivity between voriconazole, fluconazole and itraconazole"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84983266566",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "41",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "566",
                                    "@last": "567"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Benjamin Lash",
                                    "ce:indexed-name": "Benjamin Lash D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Jolliff",
                                    "ce:indexed-name": "Jolliff J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Munoz",
                                    "ce:indexed-name": "Munoz A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Heidari",
                                    "ce:indexed-name": "Heidari A."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Pharm Ther"
                        },
                        "ce:source-text": "Benjamin Lash D, Jolliff J, Munoz A, Heidari A. Cross-reactivity between voriconazole, fluconazole and itraconazole. J Clin Pharm Ther. 2016;41(5):566-567."
                    },
                    {
                        "ref-fulltext": "Pinto A, Chan RC. Lack of allergic cross-reactivity between fluconazole and voriconazole. Antimicrob Agents Chemother. 2009;53(4):1715-1716.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Lack of allergic cross-reactivity between fluconazole and voriconazole"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "65649150045",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "53",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1715",
                                    "@last": "1716"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Pinto",
                                    "ce:indexed-name": "Pinto A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan R.C."
                                }
                            ]},
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Pinto A, Chan RC. Lack of allergic cross-reactivity between fluconazole and voriconazole. Antimicrob Agents Chemother. 2009;53(4):1715-1716."
                    },
                    {
                        "ref-fulltext": "Jacobsen AA, Papo YB, Sarro R, Weisse K, Strasswimmer J. Posaconazole substitution for voriconazole-associated phototoxic effects. JAMA Dermatol. 2016;152(7):839-841.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Posaconazole substitution for voriconazole-associated phototoxic effects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84979693168",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "152",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "839",
                                    "@last": "841"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jacobsen",
                                    "ce:indexed-name": "Jacobsen A.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Papo",
                                    "ce:indexed-name": "Papo Y.B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Sarro",
                                    "ce:indexed-name": "Sarro R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Weisse",
                                    "ce:indexed-name": "Weisse K."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Strasswimmer",
                                    "ce:indexed-name": "Strasswimmer J."
                                }
                            ]},
                            "ref-sourcetitle": "JAMA Dermatol"
                        },
                        "ce:source-text": "Jacobsen AA, Papo YB, Sarro R, Weisse K, Strasswimmer J. Posaconazole substitution for voriconazole-associated phototoxic effects. JAMA Dermatol. 2016;152(7):839-841."
                    },
                    {
                        "ref-fulltext": "Patel A, Agnihotri N, Grammer L. Triazole drug allergy: successful toleration of posaconazole after reactions to fluconazole and isavuconazole. Ann Allergy Asthma Immunol. 2019;123(5):S64-S142.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Triazole drug allergy: successful toleration of posaconazole after reactions to fluconazole and isavuconazole"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jcpt13221-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088108847",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "123",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "S64",
                                    "@last": "S142"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Agnihotri",
                                    "ce:indexed-name": "Agnihotri N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Grammer",
                                    "ce:indexed-name": "Grammer L."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Allergy Asthma Immunol"
                        },
                        "ce:source-text": "Patel A, Agnihotri N, Grammer L. Triazole drug allergy: successful toleration of posaconazole after reactions to fluconazole and isavuconazole. Ann Allergy Asthma Immunol. 2019;123(5):S64-S142."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chonburi",
            "@id": "60009116",
            "affilname": "Burapha University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009116",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "120195070",
            "affilname": "Pharmacy Council",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120195070",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85088146256",
        "dc:description": "What is known and objective: Triazole antifungal-associated skin rash is rare. Data on cross-reaction triazole antifungals remain inconclusive and poorly defined. We report successful voriconazole challenge in a patient allergic to posaconazole. Case summary: A 38-year-old female diagnosed with acute myeloid leukaemia and receiving chemotherapy treatment in our institution developed a maculopapular rash after receiving oral posaconazole for invasive fungal infection prophylaxis. Other potential causes that may have attributed to this response, such as other drugs that the patient was taking and infections, were excluded. Voriconazole, another triazole antifungal, was successfully substituted for posaconazole. What is new and conclusion: This is the first case report of a patient, with a history of posaconazole allergy, successfully challenged with voriconazole.",
        "pubmed-id": "32686229",
        "prism:coverDate": "2020-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85088146256",
        "dc:creator": {"author": [{
            "ce:given-name": "Benjabhorn",
            "preferred-name": {
                "ce:given-name": "Benjabhorn",
                "ce:initials": "B.",
                "ce:surname": "Weeraphon",
                "ce:indexed-name": "Weeraphon B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "120195070",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120195070"
                },
                {
                    "@id": "60009116",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009116"
                }
            ],
            "ce:degrees": "PharmD",
            "ce:surname": "Weeraphon",
            "@auid": "57218165524",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218165524",
            "ce:indexed-name": "Weeraphon B."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85088146256"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088146256&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85088146256&origin=inward"
            }
        ],
        "source-id": "23007",
        "citedby-count": "1",
        "prism:volume": "45",
        "subtype": "ar",
        "dc:title": "Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report",
        "openaccess": "1",
        "prism:issn": "13652710 02694727",
        "publishercopyright": "© 2020 John Wiley & Sons Ltd",
        "prism:issueIdentifier": "6",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Clinical Pharmacy and Therapeutics",
        "prism:pageRange": "1486-1488",
        "prism:endingPage": "1488",
        "openaccessFlag": "true",
        "prism:doi": "10.1111/jcpt.13221",
        "prism:startingPage": "1486",
        "dc:identifier": "SCOPUS_ID:85088146256",
        "dc:publisher": "Blackwell Publishing Ltd"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antifungal Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Diagnosis, Differential",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Eruptions",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Invasive Fungal Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Leukemia, Myeloid, Acute",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Triazoles",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Voriconazole",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "antifungals"
        },
        {
            "@_fa": "true",
            "$": "cross-reactivity"
        },
        {
            "@_fa": "true",
            "$": "hypersensitivity"
        },
        {
            "@_fa": "true",
            "$": "maculopapular rash"
        },
        {
            "@_fa": "true",
            "$": "posaconazole"
        },
        {
            "@_fa": "true",
            "$": "triazole"
        },
        {
            "@_fa": "true",
            "$": "voriconazole"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Benjabhorn",
            "preferred-name": {
                "ce:given-name": "Benjabhorn",
                "ce:initials": "B.",
                "ce:surname": "Weeraphon",
                "ce:indexed-name": "Weeraphon B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "120195070",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120195070"
                },
                {
                    "@id": "60009116",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009116"
                }
            ],
            "ce:degrees": "PharmD",
            "ce:surname": "Weeraphon",
            "@auid": "57218165524",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218165524",
            "ce:indexed-name": "Weeraphon B."
        },
        {
            "ce:given-name": "Jakapat",
            "preferred-name": {
                "ce:given-name": "Jakapat",
                "ce:initials": "J.",
                "ce:surname": "Vanichanan",
                "ce:indexed-name": "Vanichanan J."
            },
            "@seq": "2",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD",
            "ce:surname": "Vanichanan",
            "@auid": "55272444700",
            "author-url": "https://api.elsevier.com/content/author/author_id/55272444700",
            "ce:indexed-name": "Vanichanan J."
        },
        {
            "ce:given-name": "Sang",
            "preferred-name": {
                "ce:given-name": "Sang",
                "ce:initials": "S.",
                "ce:surname": "Usayaporn",
                "ce:indexed-name": "Usayaporn S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "BSc(Pharm), BCIDP",
            "ce:surname": "Usayaporn",
            "@auid": "57218170494",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218170494",
            "ce:indexed-name": "Usayaporn S."
        }
    ]}
}}